| Potentiation of the cystic fibrosis transmembrane conductance regulator by VX‐770 involves stabilization of the pre‐hydrolytic, O1 state E Langron, S Prins, P Vergani British journal of pharmacology 175 (20), 3990-4002, 2018 | 17 | 2018 |
| Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity S Prins, E Langron, C Hastings, EJ Hill, AC Stefan, LD Griffin, P Vergani Journal of Biological Chemistry 295 (49), 16529-16544, 2020 | 13 | 2020 |
| Can two wrongs make a right? F508del-CFTR ion channel rescue by second-site mutations in its transmembrane domains S Prins, V Corradi, DN Sheppard, DP Tieleman, P Vergani Journal of Biological Chemistry 298 (3), 2022 | 5 | 2022 |
| Whole-cell energy modeling reveals quantitative changes of predicted energy flows in RAS mutant cancer cell lines T Sevrin, L Strasser, C Ternet, P Junk, M Caffarini, S Prins, C D’Arcy, ... iScience, 105931, 2023 | 1 | 2023 |
| K978C CFTR restores essential epithelial function with greater efficiency than wildtype CFTR when expressed in CF airway cells. MNJ Woodall, R Tarran, RE Lee, H Anfishi, S Prins, J Counsell, P Vergani, ... bioRxiv, 2022.08. 10.503368, 2022 | | 2022 |
| Illness should not curtail PhD funding ES Dalmaijer, EAC Pama, S Prins Nature 539 (7630), 495-495, 2016 | | 2016 |
